- The company priced its shares at $23 apiece on Wednesday, according to a source familiar with the offering.
- The share price values SmileDirectClub at $8.9 billion ahead of its first day of trading.
- SmileDirectClub's offering is part of a wave of digital health companies entering the public markets after a three-year drought.
- Visit Business Insider's homepage for more stories .
Digital health company SmileDirectClub is set to go public on Thursday after pricing its initial public offering on Wednesday.
The company priced its shares at $23 apiece on Wednesday, according to a source familiar with the offering. The share price values SmileDirectClub at $8.9 billion ahead of its first day of trading.
Nashville-based SmileDirectClub sold 58.5 million shares, raising $1.3 billion in the offering.
SmileDirectClub sells clear aligners for teeth, as an alternative to what you might get from an orthodontist. While it typically costs anywhere from $3,000 to $7,000 to get traditional braces or Invisalign-brand aligners, SmileDirectClub goes for a fraction of that you can either pay $1,895 up front, or a total of $2,290 spread out over two years.
The idea behind SmileDirectClub is to make straightening teeth more affordable by cutting out the steps of going in person to a dentist or orthodontist to get braces or other alignments. The company was started by Alex Fenkell and Jordan Katzman in 2014 .
In October, SmileDirectClub raised $380 million from the private-equity firm Clayton, Dubilier & Rice and the venture firms Kleiner Perkins and Spark Capital. The round valued the company at $3.2 billion , up from $275 million just two years earlier.
According to the IPO filing, SmileDirectClub's net loss widened from $33.8 million in the first half of 2018 to $52.9 million in 2018. The company has increased its customer count from 22,000 in 2016 to about 246,000 in the first half of this year.
- 3 VCs in the hottest area of healthcare explain where they're placing their next bets
- The Epstein-funded MIT lab has an ambitious project that purports to revolutionize agriculture. Insiders say it's mostly smoke and mirrors.
- Dispensed: uBiome gets dumped by CVS, Jeffrey Epstein's wacky plan to sell DNA data, and 19 unicorn startups to watch